Theta Burst TMS for Treatment of Methamphetamine Use Disorder

Status Recruiting

Clinical Trial Summary

This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Participants will be randomized to one of two groups. TMS treatment arm or sham-TMS arm.

Clinical Trial Description

Patients who meet criteria for the study and who agree to participate in the research study will be randomized to an arm of the study by chance (like tossing a coin). The chance of receiving TMS or sham-TMS is equal. They will be enrolled in either the TMS or sham-TMS group (both groups involve 5 TMS or sham-TMS sessions). The study doctor and the participant will not know whether they are in the TMS or sham-TMS group. The purpose of this study is to determine if TMS is a potential treatment for methamphetamine use disorder. TMS is a non-invasive technique that uses magnetic pulses to temporarily stimulate specific brain areas in awake people (without the need for surgery, anesthetic, or other invasive procedures). This study will test whether a specific type of TMS (intermittent theta burst) over the forehead can produce a reduction in things that may prompt you to want to use methamphetamines. ;

Study Design

Related Conditions & MeSH terms

Methamphetamine Abuse

Clinical Trial Details

NCT number	NCT06372288
Study type	Interventional
Source	Carilion Clinic
Contact	Sooraj John, M.D.
Phone	540-981-7000
Email	research@carilionclinic.org
Status	Recruiting
Phase	N/A
Start date	December 20, 2023
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05916989` - Stimulant Use and Methylation in HIV
Recruiting	`NCT04927143` - Encouraging Abstinence Behavior in a Drug Epidemic	Phase 2
Completed	`NCT03226223` - Pharmacogenetics of Naltrexone for Stimulant Abuse	Phase 2
Not yet recruiting	`NCT05593796` - Cognitive Behavioral Therapy(CBT) in Treatment of Methamphetamine Use Disorder	N/A
Completed	`NCT02907853` - Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa	N/A
Recruiting	`NCT04616625` - Cardiovascular Effects of Prenatal Methamphetamine Exposure
Completed	`NCT04061941` - Change in Cognitive Function in Stimulant Users
Completed	`NCT01967381` - Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse	Early Phase 1
Terminated	`NCT01019707` - Safety Assessment of Atomoxetine With MA IV Administration	Phase 1
Completed	`NCT01011829` - Varenicline vs Placebo for the Treatment of Methamphetamine Dependence	Phase 2
Active, not recruiting	`NCT04706624` - Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics	N/A
Recruiting	`NCT05700994` - Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)	N/A
Completed	`NCT04109014` - FASTLANE II: Reducing Sex, Drug, and Mental Health Risk	N/A
Completed	`NCT03336866` - Study of Antibody for Methamphetamine Outpatient Therapy	Phase 1/Phase 2
Completed	`NCT01822132` - Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade	N/A
Completed	`NCT01062451` - An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence	Phase 1
Not yet recruiting	`NCT06233799` - Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder	Phase 3
Recruiting	`NCT05521854` - Contingency Management for Drug Use: Does Age Matter?	N/A
Completed	`NCT01063205` - NAC as a Potential Treatment for Methamphetamine Dependence	Phase 1
Not yet recruiting	`NCT05334914` - ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals	N/A